Early Surgical Occipito-Cervical Stabilization for Plasma Cell Neoplasms at the Cranio-Cervical Junction – Systematic Review and Proposal of a Treatment Algorithm.
Ahmadi SA et al. Spine J. 2015 Sep 24. pii: S1529-9430(15)01442-4. doi: 10.1016/j.spinee.2015.09.032. [Epub ahead of print].

Pathologic sternal involvement is a potential risk factor for severe sagittal plane deformity in multiple myelomawith concomitant thoracic fractures.
Butler JS et al. Spine J. 2015 Sep 22. pii: S1529-9430(15)01407-2. doi: 10.1016/j.spinee.2015.09.031. [Epub ahead of print].

Secondary antibody deficiencies.
Dhalla F et al. Curr Opin Allergy Clin Immunol. 2015 Sep 24. [Epub ahead of print].

Bisphosphonate-related osteonecrosis of the jaw in a multiple myeloma patient: A case report with characteristic radiographic features.
Lee BD et al. Imaging Sci Dent. 2015 Sep;45(3):199-203. doi: 10.5624/isd.2015.45.3.199. Epub 2015 Sep 9.

Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors.
Valković T et al. Turk J Haematol. 2015 Sep 5;32(3):234-242. doi: 10.4274/tjh.2013.0173.

Intracranial involvement of posttransplant lymphoproliferative disorder multiple myeloma.
Wilberger AC et al. J Clin Neurosci. 2015 Sep 12. pii: S0967-5868(15)00293-3. doi: 10.1016/j.jocn.2015.06.002. [Epub ahead of print].

Light Chain Proximal Tubulopathy: Clinical and Pathologic Characteristics in the Modern Treatment Era.
Stokes MB et al. J Am Soc Nephrol. 2015 Sep 15. pii: ASN.2015020185. [Epub ahead of print].

Visceral leishmaniasis in relapsed and overtreated multiple myeloma in the era of high dose and “novel agent” therapy.
Torti L et al. Int J Hematol. 2015 Sep 10. [Epub ahead of print].

A case of primary renal allograft dysfunction due to myeloma cast nephropathy.
Lingaraj U et al. Saudi J Kidney Dis Transpl. 2015 Sep-Oct;26(5):970-5. doi: 10.4103/1319-2442.164581.

Pulmonary hypertension complicating multiple myeloma.
Krishnan U et al. Pulm Circ. 2015 Sep;5(3):590-7. doi: 10.1086/682430.

Cytomegalovirus reactivation after autologous stem cell transplantation in multiple myeloma patients treated with novel agents.
Naithani R et al. Transpl Infect Dis. 2015 Sep 1. doi: 10.1111/tid.12449. [Epub ahead of print].

Engraftment Syndrome following Autologous Stem Cell Transplantation – an Update Unifying the Definition and Management Approach.
Cornell RF et al. Biol Blood Marrow Transplant. 2015 Aug 29. pii: S1083-8791(15)00578-9. doi: 10.1016/j.bbmt.2015.08.030. [Epub ahead of print].